Top Stock Movers Now: Palantir, Sarepta Therapeutics, Denny's, and More
1. PLTR stock declined, leading Nasdaq's losses amid overvaluation concerns. 2. Despite strong quarterly results, worries about valuation persisted. 3. PLTR raised its full-year revenue outlook for the third straight quarter.